Structure Therapeutics Statistics
Total Valuation
GPCR has a market cap or net worth of $2.13 billion. The enterprise value is $1.42 billion.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GPCR has 60.68 million shares outstanding. The number of shares has increased by 15.60% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 60.68M |
| Shares Change (YoY) | +15.60% |
| Shares Change (QoQ) | +1.63% |
| Owned by Insiders (%) | 5.55% |
| Owned by Institutions (%) | 77.73% |
| Float | 40.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.88 |
| P/TBV Ratio | 2.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.15, with a Debt / Equity ratio of 0.01.
| Current Ratio | 14.15 |
| Quick Ratio | 13.89 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.28% and return on invested capital (ROIC) is -18.44%.
| Return on Equity (ROE) | -25.28% |
| Return on Assets (ROA) | -17.53% |
| Return on Invested Capital (ROIC) | -18.44% |
| Return on Capital Employed (ROCE) | -31.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.29M |
| Employee Count | 163 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GPCR has paid $481,000 in taxes.
| Income Tax | 481,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.99% in the last 52 weeks. The beta is -1.74, so GPCR's price volatility has been lower than the market average.
| Beta (5Y) | -1.74 |
| 52-Week Price Change | +14.99% |
| 50-Day Moving Average | 28.75 |
| 200-Day Moving Average | 23.01 |
| Relative Strength Index (RSI) | 63.79 |
| Average Volume (20 Days) | 1,160,574 |
Short Selling Information
| Short Interest | 5.36M |
| Short Previous Month | 4.85M |
| Short % of Shares Out | 8.83% |
| Short % of Float | 13.21% |
| Short Ratio (days to cover) | 5.64 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -247.61M |
| Pretax Income | -210.20M |
| Net Income | -210.69M |
| EBITDA | -246.40M |
| EBIT | -247.61M |
| Earnings Per Share (EPS) | -$3.65 |
Full Income Statement Balance Sheet
The company has $799.04 million in cash and $7.09 million in debt, giving a net cash position of $791.95 million or $13.05 per share.
| Cash & Cash Equivalents | 799.04M |
| Total Debt | 7.09M |
| Net Cash | 791.95M |
| Net Cash Per Share | $13.05 |
| Equity (Book Value) | 770.02M |
| Book Value Per Share | 12.69 |
| Working Capital | 756.50M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$194.25 million and capital expenditures -$2.13 million, giving a free cash flow of -$196.38 million.
| Operating Cash Flow | -194.25M |
| Capital Expenditures | -2.13M |
| Free Cash Flow | -196.38M |
| FCF Per Share | -$3.24 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GPCR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.60% |
| Shareholder Yield | -15.60% |
| Earnings Yield | -9.51% |
| FCF Yield | -8.86% |
Analyst Forecast
The average price target for GPCR is $69.57, which is 98.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $69.57 |
| Price Target Difference | 98.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -24.27% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |